IRON
Disc Medicine, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -8.3% ·
aandelenstroom -8.0% ·
netto nieuwe posities -9.1%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | +7 | 22.99M | $1.68B | +9 | −2 |
| Q1 2026 | 79 | +1 | 22.38M | $1.43B | +7 | −6 |
| Q4 2025 | 77 | -1 | 22.10M | $1.75B | +1 | −2 |
| Q3 2025 | 17 | +3 | 15.61M | $1.03B | +3 | — |
| Q2 2025 | 11 | -1 | 11.75M | $622.02M | +1 | −2 |
| Q1 2025 | 9 | -1 | 6.07M | $301.51M | — | −1 |
| Q4 2024 | 10 | +3 | 5.16M | $327.26M | +3 | — |
| Q3 2024 | 6 | -1 | 5.16M | $253.75M | — | −1 |
| Q2 2024 | 7 | — | 5.00M | $225.18M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 3.25M | — | $171.89M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 3.25M | — | $171.89M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 3.25M | — | $171.89M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 3.25M | — | $171.89M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 2.04M | — | $108.29M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 2.04M | — | $108.29M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 2.04M | — | $108.29M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 2.04M | — | $108.29M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 2.04M | — | $108.29M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 2.04M | — | $108.29M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 2.04M | — | $108.29M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 2.04M | — | $108.29M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 2.04M | — | $108.29M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 2.04M | — | $108.29M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 2.04M | — | $108.29M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 2.04M | — | $108.29M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 2.04M | — | $108.29M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 1.52M | +11.6% | $80.27M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 1.52M | +11.6% | $80.27M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Wellington Management ✦ | 1.43M | -38.9% | $75.84M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Wellington Management ✦ | 1.43M | -38.9% | $75.84M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Wellington Management ✦ | 1.43M | -38.9% | $75.84M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Wellington Management ✦ | 1.43M | -38.9% | $75.84M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | Wellington Management ✦ | 1.43M | -38.9% | $75.84M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Wellington Management ✦ | 1.43M | -38.9% | $75.84M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | Wellington Management ✦ | 1.43M | -38.9% | $75.84M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | The Vanguard Group ✦ (passief) | 1.40M | — | $73.97M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | The Vanguard Group ✦ (passief) | 1.40M | — | $73.97M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | The Vanguard Group ✦ (passief) | 1.40M | — | $73.97M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | The Vanguard Group ✦ (passief) | 1.40M | — | $73.97M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | The Vanguard Group ✦ (passief) | 1.40M | — | $73.97M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | State Street Global Advisors ✦ (passief) | 929.77K | +1.2% | $49.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 33 | Geode Capital Management ✦ (passief) | 598.59K | +4.7% | $31.71M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Geode Capital Management ✦ (passief) | 598.59K | +4.7% | $31.71M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Adage Capital Partners ✦ | 450.00K | +50.0% | $23.83M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Renaissance Technologies ✦ | 96.42K | -49.6% | $5.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 37 | Millennium Management ✦ | 21.59K | -80.1% | $1.14M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 13.65K | Nieuw | $722,851 | 0.0% | New | 1 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 13.65K | Nieuw | $722,851 | 0.0% | New | 1 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 13.65K | Nieuw | $722,851 | 0.0% | New | 1 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 13.65K | Nieuw | $722,851 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| AQR Capital Management | $722,851 | 0.0% |
| AQR Capital Management | $722,851 | 0.0% |
| AQR Capital Management | $722,851 | 0.0% |
| AQR Capital Management | $722,851 | 0.0% |
Verlaten
| D. E. Shaw & Co. | $10.90M | was 0.0% |
| Citadel Advisors | $3.09M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 203 houders, 40.63M aandelen, $2.48B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer, Director · 8.40K aand · $656,091
Officer, Director · 12.71K aand · $1.01M
Officer, Director · 11.89K aand · $949,162
Officer · 804 aand · $66,445
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie